CLSN Laboratories, Inc.

United States of America

 
Total IP 12
Total IP Rank # 127,633
IP Activity Score 0/5.0    0
IP Activity Rank # 1,666,609

Patents

Trademarks

10 0
2 0
0 0
0
 
Last Patent 2018 - Nucleic acid-lipopolymer composi...
First Patent 1999 - Hepatocyte targeting polyethylen...

Latest Inventions, Goods, Services

2017 Invention Nucleic acid-lipopolymer compositions. Compositions, methods, and applications that increase the...
2016 Invention Compositions and methods for yeast extracellular vesicles as delivery systems. The present inven...
2015 Invention Nucleic acid-lipopolymer compositions. Compositions, methods, and applications that increase the ...
2014 Invention Polyamine derivatives. Disclosed are compounds, compositions and methods for systemic and local d...
Invention Immuno gene therapy for treatment of cancer and hyperproliferative diseases. Pharmaceutical compo...
2013 Invention Compositions and methods for the delivery of biologically active rnas. The present invention pro...
2012 Invention Compositions and methods for the delivery of biologically active rnas. Novel compounds, composit...
2011 Invention Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of makin...
Invention Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferativ...
2010 Invention Polyamine derivatives. The invention relates to a composition comprising a compound of for...
Invention Compositions and methods for the delivery of biologically active rnas. The present invention prov...
2009 Invention Biodegradable cross-linked branched poly(alkylene imines). Disclosed is a cross-linked branched ...
Invention Modified poloxamers for gene expression and associated methods. Nucleotide delivery polymers, co...
2008 Invention Glp-1 gene delivery for the treatment of type 2 diabetes. This patent discloses compositions and...
2003 Invention Novel cationic lipopolymer as a biocompatible gene delivery agent. A biodegradable cationic lipop...
2002 Invention Glp-1 gene delivery for the treatment of type 2 diabetes. This patent discloses compositions and ...
2001 Invention A novel cationic lipopolymer as biocompatible gene delivery agent. A biodegradable, novel c...
Invention Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier. The present invention re...
Invention Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the deliv...
2000 Invention Cationic lipopolymer as biocompatible gene delivery agent. A biodegradable, novel cationic lipopo...
1999 Invention Polyester analogue of poly-l-lysine as a soluble, biodegradable gene delivery carrier. Poly[.alph...
Invention Hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier. A compound ...